Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Prostatic Neoplasms 32Brain Neoplasms 21Carcinoma, Non-Small-Cell Lung 19Neoplasm Metastasis 17Lung Neoplasms 15Carcinoma, Hepatocellular 13Breast Neoplasms 10Pancreatic Neoplasms 9Melanoma 9Carcinoma, Renal Cell 9Neoplasms 7Colorectal Neoplasms 7Spinal Cord Neoplasms 3Small Cell Lung Carcinoma 3Prostate Cancer Metastatic 3Nasopharyngeal Carcinoma 3Kidney Neoplasms 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Unresectable Locally Recurrent Rectal Cancer 2Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Radiation Injuries 2Osteosarcoma 2Oligometastatic Prostate Cancer 2Neuroma, Acoustic 2Neoplasms by Site 2Klatskin Tumor 2Head and Neck Neoplasms 2

Interventions

pembrolizumab 55Carboplatin 33Paclitaxel 24Cyclophosphamide 23Capecitabine 18sacituzumab govitecan 16130-nm albumin-bound paclitaxel 15Specimen Handling 14toripalimab 11Drug Therapy 11Magnetic Resonance Spectroscopy 10Biopsy 10Bevacizumab 10Taxes 9Epirubicin 9durvalumab 8Albumin-Bound Paclitaxel 8olaparib 7camrelizumab 7Gemcitabine 7Doxorubicin 7Docetaxel 7fludarabine 6famitinib 5Nivolumab 5Injections 5atezolizumab 4abemaciclib 4Trastuzumab 4Standard of Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Triple Negative Breast Neoplasms × Radiosurgery × Clear all
NCT04959474 2026-01-23

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

Thomas Jefferson University

Phase NA Recruiting
80 enrolled
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Triple Negative Breast Neoplasms

NCT06238921 2025-12-05

Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases

H. Lee Moffitt Cancer Center and Research Institute

Phase 1/2 Recruiting
31 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡